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Abstract
Background: Rare failures in amelogenin-based gender typing of individuals have been observed
globally. In this study, we report the deletion of a large fragment of the amelogenin gene in 10
individuals out of 4,257 male samples analyzed from 104 different endogamous populations of India.
Methods: Samples were analyzed using commercial genetic profiling kits. Those that exhibited
failures in amelogenin-based gender identification were further analyzed with published as well as
newly designed primers to ascertain the nature and extent of mutation.
Results: The failure rate among Indian males was 0.23 %. Though the exact size and nature of the
deletion (single point mutations at a number of positions or a single large deletion) could not be
determined in the present study, it is inferred that the deletion spans a region downstream of the
reverse primer-binding site of commercially available amelogenin primer sets. Deletions were
conspicuously absent among the Mongoloid tribes of Northeast India, while both caste and tribal
groups harbored these mutations, which was predominantly among the Y-chromosomes belonging
to J2 lineage.
Conclusion: Our study indicates that the different amelogenin primer sets currently included in
genetic profiling multiplex kits may result in erroneous interpretations due to mutations
undetectable during routine testing. Further there are indications that these mutations could
possibly be lineage-specific, inherited deletions.
Background
Genotyping the X-Y homologous amelogenin gene seg-
ment for gender identification is widely used for DNA
profiling in DNA databasing, forensic casework, archeo-
logical specimens, preimplantation and prenatal diag-
noses [1-4]. The amelogenin gene is a single copy gene,
homologues of which are located on Xp22.1-Xp22.3 and
Yp 11.2 [5]. Regions on this gene that are sufficiently con-
served are amplified for simultaneous detection of the X
and Y alleles in gender identification procedures. Primers
bind to the first intron region of the amelogenin gene on
the X and Y-chromosomes [6] and amplify regions that
differ in base sequence, hence resulting in products that
are easily distinguishable by differences in size and
sequence. The most widely used primer set [6] delimits a
6 bp deletion on the X-chromosome and produces frag-
ments of 106 bp and 112 bp for the X and Y chromosomes
respectively. Presence of two amplified products indicates
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a male genotype, while a single amplicon implies female
genotype. However, mutations in the Y-derived fragment
of the gene may result in amplification failure of the Y-
allele, causing misidentification of the biological sample
as of a female. Similarly, mutations on the X homologue
would also result in non-amplification of the X-derived
fragment although the genotype would still be identified
as male due to amplification of the Y-amelogenin allele.
Recently, a few studies have revealed misidentification of
the male genotype while employing the amelogenin gen-
der test [[7-9]]. Failures in accurate determination of gen-
der have been reported to be particularly high among
individuals of Indian origin. The frequency of failure was
observed to be 8 % by Santos et al. [7], while Thangaraj et
al. [9] reported 5 cases of amelogenin failure (1.85 %)
among the 270 Indian males studied. The failure rate of
the amelogenin sex test was particularly high (3.6 %) in
an Indian population group from Malaysia [10]. How-
ever, a parallel study testing a larger number of individu-
als from the Austrian National DNA database reported a
failure rate of 0.018 % [11]. The high frequency in inci-
dence of failures in the Indian sub-continent prompted us
to scrutinize the amelogenin typing results of 7,214 indi-
viduals (including 4,257 males) belonging to 104 differ-
ent endogamous populations that were genotyped as part
of our DNA databasing project. Individuals were sampled
from diverse geographic regions across India such that all
existing socio-ethnic groups and linguistic families were
represented. In this paper, we report failures in genotyp-
ing of male individuals due to mutations originating in
the Y-homologue of the amelogenin gene. We have fur-
ther characterized the nature and extent of mutations and
provide evidence for a plausible inherited mode of trans-
mission of the mutation.
Methods
Population samples analyzed
DNA was isolated by standard organic extraction method
[12] either from blood or buccal swabs of consenting
4,257 male and 2,957 female individuals belonging to
104 different endogamous groups. Individuals repre-
sented major caste and tribal groups of India, which were
sampled from across 20 geographical regions of India
(Table 1, Figure 1).
Amelogenin typing using commercial genotyping kits
The DNA samples were amplified using commercial mul-
tiplex short tandem repeat (STR) kits; PowerPlex® 16 sys-
tem (Promega Corporation, Madison, USA) and
Identifiler™ (Applied Biosystems, Foster City, CA), which
include the amelogenin marker for gender determination.
Genotyping of the amplified products was performed on
an ABI Prism™ 377 DNA Sequencer (PE Applied Biosys-
tems, Foster City, CA). The amelogenin profile was deter-
mined from the electropherograms by comparing the
presence or absence of 106 and 112 bp peaks with known
male and female controls. Females exhibit a single peak of
106 bp while males exhibit two peaks of 106 and 112 bps.
Amelogenin typing using newly designed primers and other 
published primers
Samples that showed abnormal amelogenin peak profiles
with the commercial kits were reamplified with primers
described by Steinlechner et al. [11] followed by genotyp-
ing as described above. Male samples exhibit two peaks of
219 and 225 bp, while female samples exhibit a single
peak at 219 bp.
Additional primers were designed for amplifying the
region identified by Roffey et al. [8] to decipher the origin
of mutations. The sequences of new primers designed to
facilitate detection of mutation are as follows:
1. #P1: 5'- TTACGGCCATATTTAGGA-3' (for amplifica-
tion of X and Y homologues)
2. #P2: 5'- GAAAGAGTCAATCCGAATGGT-3' (for amplifi-
cation of Y homologue)
Analysis of SRY, Y-STRs and Y-SNPs
To confirm the gender of the studied samples, a sex-deter-
mining locus (SRY) [13] specific to males, was amplified.
Occurrence of a single 93 bp amplicon would distinguish
an authentic male DNA sample from a female DNA sam-
ple. Further, four Y- short tandem repeats (Y-STRs)
[14,15] (DYS19, DYS389I, DYS389II and DYS390) were
amplified to determine the extent of deletion of the Y-
Map depicting the regions covered in the study and location  of samples where amelogenin deletion were observed Figure 1
Map depicting the regions covered in the study and location 
of samples where amelogenin deletion were observed.
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Table 1: Incidences in failures of gender testing among the 104 endogamous populations of India tested for amelogerin gene efficacy
S.No State Population Social Group Individuals Tested Failure in Gender Analysis 
(No of samples)
1 Jammu & kashmir Balti Tribe 67 Nil
Drokpa Tribe 38 Nil
Argon Tribe 51 Nil
Buddhist Religious Group 156 Nil
2 Himachal Pradesh HPRajput Caste 50 Nil
3 Uttaranchal Tharu Tribe 45 Nil
Jaunsari Tribe 45 Nil
Bhoksha Tribe 42 Nil
4 Uttar Pradesh Kanyakubj Brahmin Caste 98 Nil
UP Jat Caste 48 Nil
UP Thakur Caste 48 Nil
Khatri Caste 47 1
UP Kurmi Caste 45 Nil
5B i h a r Bihar Brahmin Caste 59 Nil
Bhumihar Caste 65 Nil
Rajput Caste 58 Nil
Kayasth Caste 53 Nil
Yadav Caste 44 Nil
Kurmi Caste 50 Nil
Baniya Caste 45 Nil
6 Gujarat Gujarat Patel Caste 45 Nil
7 Maharastra Desasth Brahmin Caste 70 1
Chitpavan Brahmin Caste 78 Nil
Maratha Caste 65 1
Dhangar Caste 150 Nil
Pawara Tribe 82 Nil
Katkari Tribe 95 Nil
Madia Gond Tribe 45 Nil
Mahadeo Koli Tribe 45 Nil
8 Chattisgarh Brahmin Caste 51 Nil
Satnami Caste 50 Nil
Teli Caste 50 Nil
Dheria Gond Tribe 35 Nil
Agharia Tribe 70 1
Oroan Tribe 42 Nil
9 Jharkhand Ho Tribe 50 Nil
Bhumij Tribe 56 Nil
Kharia Tribe 83 Nil
Munda Tribe 64 Nil
Birhor Tribe 61 Nil
Santhal Tribe 61 Nil
Oroan Tribe 60 Nil
10 Westbengal Brahmin Caste 110 Nil
Kayasth Caste 103 Nil
Mahishya Caste 60 Nil
Namasudra Caste 55 Nil
Bauri Caste 54 Nil
Maheli Tribe 49 Nil
Karmali Tribe 51 Nil
Kora Tribe 59 Nil
Lodha Tribe 99 Nil
11 Orrisa Oriya Brahmin Caste 57 Nil
Karan Caste 62 Nil
Khandayat Caste 62 1
Gope Caste 60 Nil
Paroja Tribe 78 1
Juang  Tribe 50 Nil
Saora Tribe 35 Nil
12 Andhra Pradesh Andhra Brahmin Caste 106 NilBMC Medical Genetics 2006, 7:37 http://www.biomedcentral.com/1471-2350/7/37
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chromosome and to determine if Y-STR haplotype pro-
files were shared between individuals. Y-STR amplifica-
tion was carried out in a single tube multiplex reaction
[14] and genotyped on an ABI Prism™ 377 DNA
Sequencer (PE Applied Biosystems, Foster City, CA). Y-
single nucleotide polymorphisms (Y-SNPs) (M89, M9,
M172, 92R7, M45, M20, M70, M214, M69, M124, M173,
M17) [16] were profiled hierarchically to identify the lin-
eage of the test samples.
Results and Discussion
Out of the 4,257 males analyzed with either PowerPlex®
16 or Identifiler™ multiplex system, 10 confirmed male
samples exhibited a dropout of the 112 bp amelogenin Y-
allele (Table 1). To verify the cause of observed abnormal-
ities, we tested such samples with alternate primer pairs
that encompassed the region amplified with primers
reported by Sullivan et al. [6] and, are also typically used
in the commercial kits. Amplification of the test samples
with the primer set described by Steinlechner et al. [11]
Raju Caste 66 Nil
Kappu Naidu Caste 104 Nil
Kamma Chaudhary Caste 106 Nil
Reddy Caste 107 Nil
Komati Caste 104 Nil
Yerukula Tribe 101 Nil
Chenchu Tribe 100 Nil
Naikpod Gond Tribe 104 Nil
Lambadi Tribe 107 Nil
Golla Caste 65 Nil
Sakunupakshollu Caste 30 Nil
13 Tamil Nadu Chakkiliar Caste 49 Nil
Tanjore Kallar Caste 101 1
Vanniyar Caste 87 1
Pallar Caste 33 Nil
Gounder Caste 56 Nil
Irular Tribe 54 Nil
Paraiyar Caste 21 Nil
14 Kerala Nair Caste 87 Nil
15 Karnataka Iyenger Brahmin Caste 65 1
Lingayat Caste 98 Nil
Gowda Caste 56 Nil
Bhovi Caste 52 Nil
Christian Religious Group 55 Nil
Muslim Religious Group 65 Nil
Kuruva Tribe 60 1
16 Sikkim Bhutia Tribe 75 Nil
Nepali Caste 110 Nil
Lepcha Tribe 48 Nil
17 Mizoram Mara Tribe 90 Nil
Hmar Tribe 80 Nil
Lai Tribe 92 Nil
Lusei Tribe 92 Nil
Kuki Tribe 105 Nil
18 Arunachal Pradesh Adi Pasi Tribe 203 Nil
19 Manipur Garo Tribe 110 Nil
Meitei Tribe 105 Nil
Naga Tribe 106 Nil
Hmar Tribe 101 Nil
Manipuri Muslim Religious Group 101 Nil
20 Andaman & Nicobar 
Islands
Great Andamanese Tribe 24 Nil
Jarawa Tribe 50 Nil
Onge Tribe 16 Nil
Nicobarese Tribe 28 Nil
Shompen Tribe 33 Nil
* NUMBER OF POPULATIONS ANALYZED: 104; 4257 MALES OUT OF 7214 INDIVIDUALS ANALYZED IN GENETIC PROFILING
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resulted in complete absence of the 225 bp Y-specific
product.
All 10 ambiguous samples were confirmed to be from
male individuals on testing with male-specific SRY locus,
which yielded the characteristic 93 bp amplicon recon-
firming the gender of these subjects as males.
Additional analysis with four Y-chromosomal STR mark-
ers, DYS19, DYS389I, DYS389II and DYS390, yielded
complete and different Y-STR haplotype profiles. Amplifi-
cation of Y-STR indicates that these samples had failed the
amelogenin typing either due to mutation in the primer-
binding region [17] or due to deletions in the amelogenin
region (11.2p) on the Y-chromosome [11]. Among the 10
samples, eight distinct Y-STR haplotype profiles were
observed; one was shared between Khatri and Kuruva and,
another one by Agharia and Kallar (Table 2). Further
amplification and sequencing was carried out using the
forward primer of Steinlechner et al. [11] and a set of
newly designed reverse primers spanning the hypothetical
region of mutation – #P1, which is 62 bp downstream,
and #P2, a Y-specific primer that is 43 bp downstream to
the Steinlechner's reverse primer binding region, in order
to determine the nature and extent of mutation. The
newly designed primers depicted in Fig.2, result in 287 bp
and 268 bp amplicon for #P1 and #P2 respectively, for the
Y-chromosome, when used along with the forward primer
of Steinlechner et al., #P1 results in a 281 bp product for
the X-chromosome. However, the newly designed and
validated primer sets also failed to amplify the Y-homo-
logue in test samples suggesting deletion of a significant
portion of the amelogenin region in male samples. The
deletion in amelogenin gene has recently been mapped to
span around 2.5 Mb [18].
The overall rate of failure among the Indian population
was found to be 0.23%. Table 1 shows the frequency of
failure among different endogamous groups. Failures
were exhibited by both caste groups (Khatri, Desasth
Brahmin, Maratha, Khandayat, Tanjore Kallar, Vanniyar
and Iyenger Brahmin) and tribal populations (Agharia,
Paroja, and Kuruva) while Mongoloid and Negrito popu-
lations were not found to harbor the deletions (Fig. 1).
Interestingly, we observed that these deletions were
present predominantly in individuals belonging to the J2
Y-chromosomal lineage. J2 is found in approximately
5.1% of the Indian population, while majority of the
Indian males harbor H (25%), R1a1 (19%) and R2 (16%)
haplogroups in their Y-chromosomes [19]. Probably orig-
inating in the Middle East [20], the J2 lineage has been
found distributed across southeastern Europe and Asia
with frequencies of 6.5% in Central Asians [16], 23.8% in
Sephardic Jews, 20% in Lebanese, 17.8% in Konyan
Turks, 16.3% among Italians of Apulia, 13.6% in French
Basque [20], 10.2% in Moroccan Arabs [21]. The above
observations and positive amplification of the SRY gene
and the appearance of discrete Y-STR haplotypes, suggests
that the mutations probably arose independently on a J2
Y chromosome lineage background.
Of the endogamous populations screened in this study,
~10 % exhibited failures in the amelogenin gender test.
Since the extent of deletion is large to avoid amplification
dropout of the Y-homologue with currently available
commercial primer sets, we suggest it would be prudent to
include an additional gender test such as SRY and/or Y-
STR testing for accurate gender identification of biological
specimens.
Conclusion
Earlier studies have reported high failure rates in amelo-
genin-based gender testing of individuals from the Indian
sub-continent. In this study, we have analyzed 4,257 male
samples and report a failure rate of 0.23%. Due to ease of
typing, this test has gained wide acceptance and has been
integrated into routine automated genetic profiling proce-
dures. However, the fallibility of the amelogenin test
Table 2: Y-chromosome profiles of the amelogenin-deletion individuals*
S. No Sample Y-SNP DYS 19 DYS 389I DYS 389II DYS 390
1 Kallar NA 15 12 29 25
2 V a n n i y a r J 21 51 32 92 4
3 Agharia NA 15 12 29 25
4K h a t r i N A 15 13 30 25
5 I y e n g e r  B r a h m i n J 21 41 32 92 4
6K u r u v a N A 15 13 30 25
7 Khandayat J2 15 11 30 23
8 P a r o j a J 21 51 32 62 5
9 Desasth Brahmin J2 14 13 30 23
1 0M a r a t h a J 21 51 12 82 5
NA: Samples not be examined for Y-SNPs    
* Integers in bold represent shared haplotype between Kallar and Agahria; while those in bold italics represent haploype sharing between Khatri and 
Kuruva  BMC Medical Genetics 2006, 7:37 http://www.biomedcentral.com/1471-2350/7/37
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raises concern over its continued use especially in medical
and forensic sciences.
Although our study indicates that individuals belonging
to the J2 lineage are more prone to deletion in Y-derived
amelogenin gene, further corroborating studies are
desired. The amelogenin-based gender test thus needs to
be applied with caution, with supplementation with other
Y-chromosome specific analyses for reliable gender iden-
tification.
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tion of annealing regions of the primer sets used in this study.
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